Ashland Inc is a prominent supplier to the pharmaceutical industry, specialising in the manufacturing and provision of active pharmaceutical ingredients, excipients, and innovative drug delivery systems. Founded in 1924, Ashland has been delivering pharmaceutical and nutraceutical performance since the 1950s. The company boasts a broad portfolio of cellulose-based polymers such as HPMC, HPC, CMC, and HEC, as well as excipients for injectables and biologics. Ashland focuses on enhancing oral solid and liquid dosage forms while providing customisation options and advanced film coating technologies. Their expertise encompasses a range of functionalities, including controlled release, disintegration, and binding, which positions Ashland as a pivotal entity in the realm of pharmaceutical excipients.

Services include:
– Regulatory Services
– Clinical Dose
– Analytical Services
– Anatomical Therapeutic Chemical (ATC) Classification
– Drug Delivery Devices & Systems
– Excipients
– Finished Dosage Forms
– Machinery & Equipment
– Accelerated Stability Studies
– Bioavailability Studies
– Contract Manufacturing (CMO)
– Dissolution Testing
– Dosage Form Development
– Drug Delivery Devices
– Encapsulation
– Formulation Development
– Controlled Release
– Hot Melt Extrusion
– Particle Characterization
– Particle Size Analysis
– Preformulation
– Stability Studies
– Sustained Release Delivery Systems

Ashland Inc continues to create value for its customers through extensive applications knowledge, regulatory support, and a powerful product portfolio, ensuring a leading position in the pharmaceutical industry. For more information, please visit ashland.com.